Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,383,203
+$6,476,371 QoQ
Shares Held
724,604
+37.5% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 254 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. PCRX ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in PCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,383,203 | 724,604 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,906,832 | 526,851 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,693,929 | 451,852 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,004,255 | 232,994 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,553,523 | 106,842 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,940,848 | 118,344 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,160,608 | 114,682 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,045,373 | 69,460 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,175,018 | 76,023 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,206,602 | 109,740 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,211,637 | 35,911 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,974,333 | 96,947 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,738,905 | 143,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,031,840 | 25,284 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $1,342,774 | 17,594 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,060,271 | 67,480 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,153,168 | 109,878 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,222,897 | 366,231 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,192,311 | 88,348 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,976,952 | 83,171 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,826,397 | 146,813 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $1,330,302 | 39,675 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||